{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:17:06Z","timestamp":1793222226928,"version":"4.5.0"},"reference-count":168,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41582-026-01205-y","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:53:48Z","timestamp":1776092028000},"page":"351-365","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Understanding the long-term neurological effects of SARS-CoV-2 infection"],"prefix":"10.1038","volume":"22","author":[{"given":"Rachael","family":"Matthews","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed","family":"Bullmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8693-8926","authenticated-orcid":false,"given":"Benedict D.","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"1205_CR1","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard (WHO, 2025); https:\/\/data.who.int\/dashboards\/covid19\/cases?n=c2025."},{"key":"1205_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S2352-4642(21)00193-0","volume":"5","author":"STJ Ray","year":"2021","unstructured":"Ray, S. T. J. et al. Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study. Lancet Child Adolesc. Health 5, 631\u2013641 (2021).","journal-title":"Lancet Child Adolesc. Health"},{"key":"1205_CR3","doi-asserted-by":"publisher","first-page":"fcab168","DOI":"10.1093\/braincomms\/fcab168","volume":"3","author":"Ross Russell AL","year":"2021","unstructured":"Ross Russell AL et al. Spectrum, risk factors and outcomes of neurological and psychiatric complications of COVID-19: a UK-wide cross-sectional surveillance study. Brain Commun. 3, fcab168 (2021).","journal-title":"Brain Commun."},{"key":"1205_CR4","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S2215-0366(20)30287-X","volume":"7","author":"A Varatharaj","year":"2020","unstructured":"Varatharaj, A. et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry 7, 875\u2013882 (2020).","journal-title":"Lancet Psychiatry"},{"key":"1205_CR5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.12131","volume":"4","author":"SH Chou","year":"2021","unstructured":"Chou, S. H. et al. Global incidence of neurological manifestations among patients hospitalized with COVID-19 \u2014 a report for the GCS\u2013NeuroCOVID Consortium and the ENERGY Consortium. JAMA Netw. Open 4, e2112131 (2021).","journal-title":"JAMA Netw. Open"},{"key":"1205_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-22987-8","volume":"25","author":"J Shi","year":"2025","unstructured":"Shi, J. et al. Prevalence of and factors associated with long COVID among US adults: a nationwide survey. BMC Public Health 25, 1758 (2025).","journal-title":"BMC Public Health"},{"key":"1205_CR7","unstructured":"World Health Organization. Post COVID-19 condition (long COVID). who.int https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/post-covid-19-condition-%28long-covid%29 (accessed 25 June 2025)."},{"key":"1205_CR8","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","volume":"22","author":"JB Soriano","year":"2022","unstructured":"Soriano, J. B., Murthy, S., Marshall, J. C., Relan, P. & Diaz, J. V. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 22, e102\u2013e107 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"1205_CR9","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S2213-2600(22)00169-2","volume":"10","author":"D Munblit","year":"2022","unstructured":"Munblit, D. et al. A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study. Lancet Respir. Med. 10, 715\u2013724 (2022).","journal-title":"Lancet Respir. Med."},{"key":"1205_CR10","first-page":"1","volume":"480","author":"D Adjaye-Gbewonyo","year":"2023","unstructured":"Adjaye-Gbewonyo D., Vahratian A., Perrine C. G. & Bertolli J. Long COVID in adults: United States, 2022. NCHS Data Brief. 480, 1\u20138 (2023).","journal-title":"NCHS Data Brief."},{"key":"1205_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf533","volume":"12","author":"Y Hou","year":"2025","unstructured":"Hou, Y. et al. Global prevalence of long COVID, its subtypes, and risk factors: an updated systematic review and meta-analysis. Open Forum Infect. Dis. 12, ofaf533 (2025).","journal-title":"Open Forum Infect. Dis."},{"key":"1205_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-025-04174-9","volume":"25","author":"T Elboraay","year":"2025","unstructured":"Elboraay, T. et al. Long-term neurological and cognitive impact of COVID-19: a systematic review and meta-analysis in over 4 million patients. BMC Neurol. 25, 250 (2025).","journal-title":"BMC Neurol."},{"key":"1205_CR13","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1038\/s41591-022-01909-w","volume":"28","author":"A Subramanian","year":"2022","unstructured":"Subramanian, A. et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 28, 1706\u20131714 (2022).","journal-title":"Nat. Med."},{"key":"1205_CR14","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41591-021-01292-y","volume":"27","author":"CH Sudre","year":"2021","unstructured":"Sudre, C. H. et al. Attributes and predictors of long COVID. Nat. Med. 27, 626\u2013631 (2021).","journal-title":"Nat. Med."},{"key":"1205_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30836-0","volume":"13","author":"EJ Thompson","year":"2022","unstructured":"Thompson, E. J. et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat. Commun. 13, 3528 (2022).","journal-title":"Nat. Commun."},{"key":"1205_CR16","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/S1473-3099(22)00223-7","volume":"22","author":"E Burn","year":"2022","unstructured":"Burn, E. et al. Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study. Lancet Infect. Dis. 22, 1142\u20131152 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"1205_CR17","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1161\/STROKEAHA.120.031786","volume":"52","author":"AI Qureshi","year":"2021","unstructured":"Qureshi, A. I. et al. Acute ischemic stroke and COVID-19: an analysis of 27,676 patients. Stroke 52, 905\u2013912 (2021).","journal-title":"Stroke"},{"key":"1205_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/1747493020972922","volume":"16","author":"S Nannoni","year":"2021","unstructured":"Nannoni, S., de Groot, R., Bell, S. & Markus, H. S. Stroke in COVID-19: a systematic review and meta-analysis. Int. J. Stroke 16, 137\u2013149 (2021).","journal-title":"Int. J. Stroke"},{"key":"1205_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.904796","volume":"13","author":"P Zarifkar","year":"2022","unstructured":"Zarifkar, P., Peinkhofer, C., Benros, M. E. & Kondziella, D. Frequency of neurological diseases after COVID-19, influenza A\/B and bacterial pneumonia. Front. Neurol. 13, 904796 (2022).","journal-title":"Front. Neurol."},{"key":"1205_CR20","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/jmv.26207","volume":"93","author":"RK Garg","year":"2021","unstructured":"Garg, R. K., Paliwal, V. K. & Gupta, A. Encephalopathy in patients with COVID-19: a review. J. Med. Virol. 93, 206\u2013222 (2021).","journal-title":"J. Med. Virol."},{"key":"1205_CR21","doi-asserted-by":"publisher","first-page":"e2247","DOI":"10.1212\/WNL.0000000000207263","volume":"100","author":"S Legriel","year":"2023","unstructured":"Legriel, S. et al. Outcomes in patients with COVID-19 with acute encephalopathy and coma: an international prospective study. Neurology 100, e2247\u2013e2258 (2023).","journal-title":"Neurology"},{"key":"1205_CR22","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1002\/acn3.51210","volume":"7","author":"EM Liotta","year":"2020","unstructured":"Liotta, E. M. et al. Frequent neurologic manifestations and encephalopathy-associated morbidity in COVID-19 patients. Ann. Clin. Transl. Neurol. 7, 2221\u20132230 (2020).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1205_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101762","volume":"55","author":"LL O\u2019Mahoney","year":"2023","unstructured":"O\u2019Mahoney, L. L. et al. The prevalence and long-term health effects of long COVID among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine 55, 101762 (2023).","journal-title":"EClinicalMedicine"},{"key":"1205_CR24","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.1111\/ene.15040","volume":"28","author":"C Fern\u00e1ndez-de-Las-Pe\u00f1as","year":"2021","unstructured":"Fern\u00e1ndez-de-Las-Pe\u00f1as, C. et al. Headache as an acute and post-COVID-19 symptom in COVID-19 survivors: a meta-analysis of the current literature. Eur. J. Neurol. 28, 3820\u20133825 (2021).","journal-title":"Eur. J. Neurol."},{"key":"1205_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-022-01450-8","volume":"23","author":"C Tana","year":"2022","unstructured":"Tana, C. et al. Long COVID headache. J. Headache Pain. 23, 93 (2022).","journal-title":"J. Headache Pain."},{"key":"1205_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/ene.70130","volume":"32","author":"L Silva","year":"2025","unstructured":"Silva, L. et al. Long-term persistent headache after SARS-CoV-2 infection: a follow-up population-based study. Eur. J. Neurol. 32, e70130 (2025).","journal-title":"Eur. J. Neurol."},{"key":"1205_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01188-1","volume":"21","author":"O Uygun","year":"2020","unstructured":"Uygun, O. et al. Headache characteristics in COVID-19 pandemic \u2014 a survey study. J. Headache Pain 21, 121 (2020).","journal-title":"J. Headache Pain"},{"key":"1205_CR28","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1177\/0333102420965157","volume":"40","author":"E Caronna","year":"2020","unstructured":"Caronna, E. et al. Headache: a striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia 40, 1410\u20131421 (2020).","journal-title":"Cephalalgia"},{"key":"1205_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01165-8","volume":"21","author":"J Trigo","year":"2020","unstructured":"Trigo, J. et al. Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: a retrospective cohort study. J. Headache Pain 21, 94 (2020).","journal-title":"J. Headache Pain"},{"key":"1205_CR30","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1007\/s10072-020-04978-2","volume":"42","author":"\u00d6 Karada\u015f","year":"2021","unstructured":"Karada\u015f, \u00d6 et al. Latent class cluster analysis identified hidden headache phenotypes in COVID-19: impact of pulmonary infiltration and IL-6. Neurol. Sci. 42, 1665\u20131673 (2021).","journal-title":"Neurol. Sci."},{"key":"1205_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101019","volume":"38","author":"HE Davis","year":"2021","unstructured":"Davis, H. E. et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine 38, 101019 (2021).","journal-title":"eClinicalMedicine"},{"key":"1205_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.1012668","volume":"13","author":"NW Larsen","year":"2022","unstructured":"Larsen, N. W. et al. Characterization of autonomic symptom burden in long COVID: a global survey of 2,314 adults. Front. Neurol. 13, 1012668 (2022).","journal-title":"Front. Neurol."},{"key":"1205_CR33","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/ana.26286","volume":"91","author":"P Novak","year":"2022","unstructured":"Novak, P. et al. Multisystem involvement in post-acute sequelae of coronavirus disease 19. Ann. Neurol. 91, 367\u2013379 (2022).","journal-title":"Ann. Neurol."},{"key":"1205_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2021.102841","volume":"235","author":"NW Larsen","year":"2021","unstructured":"Larsen, N. W., Stiles, L. E. & Miglis, M. G. Preparing for the long-haul: autonomic complications of COVID-19. Auton. Neurosci. 235, 102841 (2021).","journal-title":"Auton. Neurosci."},{"key":"1205_CR35","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.mayocp.2012.10.013","volume":"87","author":"DM Sletten","year":"2012","unstructured":"Sletten, D. M., Suarez, G. A., Low, P. A., Mandrekar, J. & Singer, W. COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score. Mayo Clin. Proc. 87, 1196\u20131201 (2012).","journal-title":"Mayo Clin. Proc."},{"key":"1205_CR36","doi-asserted-by":"publisher","first-page":"4290","DOI":"10.1212\/WNL.0000000000211574","volume":"104","author":"E Eastin","year":"2025","unstructured":"Eastin, E. et al. Evaluating long-term autonomic dysfunction and functional impacts of long COVID: a follow-up study (P1-7.004). Neurology 104, 4290 (2025).","journal-title":"Neurology"},{"key":"1205_CR37","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.7861\/clinmed.2020-0896","volume":"21","author":"M Dani","year":"2021","unstructured":"Dani, M. et al. Autonomic dysfunction in \u2018long COVID\u2019: rationale, physiology and management strategies. Clin. Med. 21, e63\u2013e67 (2021).","journal-title":"Clin. Med."},{"key":"1205_CR38","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S0140-6736(23)00810-3","volume":"401","author":"C Huang","year":"2023","unstructured":"Huang, C. et al. 6-Month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 401, e21\u2013e33 (2023).","journal-title":"Lancet"},{"key":"1205_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.13754","volume":"32","author":"I Merikanto","year":"2023","unstructured":"Merikanto, I. et al. Sleep symptoms are essential features of long-COVID \u2014 comparing healthy controls with COVID-19 cases of different severity in the International COVID Sleep Study (ICOSS-II). J. Sleep Res. 32, e13754 (2023).","journal-title":"J. Sleep Res."},{"key":"1205_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-022-02940-7","volume":"22","author":"AEF Moura","year":"2022","unstructured":"Moura, A. E. F. et al. Central hypersomnia and chronic insomnia: expanding the spectrum of sleep disorders in long COVID syndrome \u2014 a prospective cohort study. BMC Neurol. 22, 417 (2022).","journal-title":"BMC Neurol."},{"key":"1205_CR41","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1097\/CCM.0000000000006298","volume":"52","author":"M Henr\u00edquez-Beltr\u00e1n","year":"2024","unstructured":"Henr\u00edquez-Beltr\u00e1n, M. et al. Sleep and circadian health of critical survivors: a 12-month follow-up study. Crit. Care Med. 52, 1206\u20131217 (2024).","journal-title":"Crit. Care Med."},{"key":"1205_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2023.111535","volume":"175","author":"C Chinvararak","year":"2023","unstructured":"Chinvararak, C. & Chalder, T. Prevalence of sleep disturbances in patients with long COVID assessed by standardised questionnaires and diagnostic criteria: a systematic review and meta-analysis. J. Psychosom. Res. 175, 111535 (2023).","journal-title":"J. Psychosom. Res."},{"key":"1205_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2023.101833","volume":"71","author":"TTD Linh","year":"2023","unstructured":"Linh, T. T. D. et al. Global prevalence of post-COVID-19 sleep disturbances in adults at different follow-up time points: a systematic review and meta-analysis. Sleep Med. Rev. 71, 101833 (2023).","journal-title":"Sleep Med. Rev."},{"key":"1205_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102719","volume":"74","author":"J Zhou","year":"2024","unstructured":"Zhou, J. et al. Pre-existing sleep disturbances and risk of COVID-19: a meta-analysis. eClinicalMedicine 74, 102719 (2024).","journal-title":"eClinicalMedicine"},{"key":"1205_CR45","doi-asserted-by":"publisher","DOI":"10.1177\/21501319241233205","volume":"15","author":"M Punj","year":"2024","unstructured":"Punj, M., Schwartz, M., Morris, A., Cheung, J. & Munipalli, B. A survey of sleep quality from a post-COVID clinic. J. Prim. Care Commun. Health 15, 21501319241233205 (2024).","journal-title":"J. Prim. Care Commun. Health"},{"key":"1205_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2022.100476","volume":"23","author":"CA Goldstein","year":"2022","unstructured":"Goldstein, C. A. et al. The possibility of circadian rhythm disruption in long COVID. Brain Behav. Immun. Health 23, 100476 (2022).","journal-title":"Brain Behav. Immun. Health"},{"key":"1205_CR47","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1001\/jama.2022.18931","volume":"328","author":"Global Burden of Disease Long COVID Collaborators","year":"2022","unstructured":"Global Burden of Disease Long COVID Collaborators. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA 328, 1604\u20131615 (2022).","journal-title":"JAMA"},{"key":"1205_CR48","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.2023.8823","volume":"329","author":"T Thaweethai","year":"2023","unstructured":"Thaweethai, T. et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA 329, 1934\u20131946 (2023).","journal-title":"JAMA"},{"key":"1205_CR49","doi-asserted-by":"publisher","first-page":"e071050","DOI":"10.1136\/bmj-2022-071050","volume":"379","author":"RS Peter","year":"2022","unstructured":"Peter, R. S. et al. Post-acute sequelae of COVID-19 six to 12 months after infection: population based study. Br. Med. J. 379, e071050 (2022).","journal-title":"Br. Med. J."},{"key":"1205_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.947973","volume":"13","author":"J Joli","year":"2022","unstructured":"Joli, J., Buck, P., Zipfel, S. & Stengel, A. Post-COVID-19 fatigue: a systematic review. Front. Psychiatry 13, 947973 (2022).","journal-title":"Front. Psychiatry"},{"key":"1205_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32507-6","volume":"13","author":"C Kedor","year":"2022","unstructured":"Kedor, C. et al. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat. Commun. 13, 5104 (2022).","journal-title":"Nat. Commun."},{"key":"1205_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44432-3","volume":"15","author":"B Appelman","year":"2024","unstructured":"Appelman, B. et al. Muscle abnormalities worsen after post-exertional malaise in long COVID. Nat. Commun. 15, 17 (2024).","journal-title":"Nat. Commun."},{"key":"1205_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1341843","volume":"15","author":"S Saito","year":"2024","unstructured":"Saito, S. et al. Metabolomic and immune alterations in long COVID patients with chronic fatigue syndrome. Front. Immunol. 15, 1341843 (2024).","journal-title":"Front. Immunol."},{"key":"1205_CR54","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1177\/17423953211043106","volume":"18","author":"LA Jason","year":"2022","unstructured":"Jason, L. A., Yoo, S. & Bhatia, S. Patient perceptions of infectious illnesses preceding myalgic encephalomyelitis\/chronic fatigue syndrome. Chronic Illn. 18, 901\u2013910 (2022).","journal-title":"Chronic Illn."},{"key":"1205_CR55","doi-asserted-by":"publisher","first-page":"945","DOI":"10.2967\/jnumed.113.131045","volume":"55","author":"Y Nakatomi","year":"2014","unstructured":"Nakatomi, Y. et al. Neuroinflammation in patients with chronic fatigue syndrome\/myalgic encephalomyelitis: an (1)(1)C-(R)-PK11195 PET study. J. Nucl. Med. 55, 945\u2013950 (2014).","journal-title":"J. Nucl. Med."},{"key":"1205_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1187163","volume":"10","author":"AL Komaroff","year":"2023","unstructured":"Komaroff, A. L. & Lipkin, W. I. ME\/CFS and long COVID share similar symptoms and biological abnormalities: road map to the literature. Front. Med. 10, 1187163 (2023).","journal-title":"Front. Med."},{"key":"1205_CR57","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/jnnp-2022-329683","volume":"94","author":"L McWhirter","year":"2023","unstructured":"McWhirter, L. et al. What is brain fog? J. Neurol. Neurosurg. Psychiatry 94, 321\u2013325 (2023).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1205_CR58","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1038\/s41591-022-02001-z","volume":"28","author":"E Xu","year":"2022","unstructured":"Xu, E., Xie, Y. & Al-Aly, Z. Long-term neurologic outcomes of COVID-19. Nat. Med. 28, 2406\u20132415 (2022).","journal-title":"Nat. Med."},{"key":"1205_CR59","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1038\/s41591-024-03173-6","volume":"30","author":"Z Al-Aly","year":"2024","unstructured":"Al-Aly, Z. et al. Long COVID science, research and policy. Nat. Med. 30, 2148\u20132164 (2024).","journal-title":"Nat. Med."},{"key":"1205_CR60","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1056\/NEJMe2400189","volume":"390","author":"Z Al-Aly","year":"2024","unstructured":"Al-Aly, Z. & Rosen, C. J. Long COVID and impaired cognition \u2014 more evidence and more work to do. N. Engl. J. Med. 390, 858\u2013860 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1205_CR61","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1056\/NEJMoa2311330","volume":"390","author":"A Hampshire","year":"2024","unstructured":"Hampshire, A. et al. Cognition and memory after COVID-19 in a large community sample. N. Engl. J. Med. 390, 806\u2013818 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1205_CR62","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41591-024-03309-8","volume":"31","author":"GK Wood","year":"2025","unstructured":"Wood, G. K. et al. Posthospitalization COVID-19 cognitive deficits at 1\u2009year are global and associated with elevated brain injury markers and gray matter volume reduction. Nat. Med. 31, 245\u2013257 (2025).","journal-title":"Nat. Med."},{"key":"1205_CR63","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1093\/brain\/awab009","volume":"144","author":"JA Hosp","year":"2021","unstructured":"Hosp, J. A. et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain 144, 1263\u20131276 (2021).","journal-title":"Brain"},{"key":"1205_CR64","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1093\/brain\/awae101","volume":"147","author":"VM Serrano del Pueblo","year":"2024","unstructured":"Serrano del Pueblo, V. M. et al. Brain and cognitive changes in patients with long COVID compared with infection-recovered control subjects. Brain 147, 3611\u20133623 (2024).","journal-title":"Brain"},{"key":"1205_CR65","doi-asserted-by":"publisher","first-page":"e2130645","DOI":"10.1001\/jamanetworkopen.2021.30645","volume":"4","author":"JH Becker","year":"2021","unstructured":"Becker, J. H. et al. Assessment of cognitive function in patients after COVID-19 infection. JAMA Netw. Open 4, e2130645 (2021).","journal-title":"JAMA Netw. Open"},{"key":"1205_CR66","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16181","volume":"32","author":"JB Fanshawe","year":"2025","unstructured":"Fanshawe, J. B. et al. Cognitive domains affected post-COVID-19; a systematic review and meta-analysis. Eur. J. Neurol. 32, e16181 (2025).","journal-title":"Eur. J. Neurol."},{"key":"1205_CR67","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1016\/j.cell.2022.06.008","volume":"185","author":"A Fernandez-Castaneda","year":"2022","unstructured":"Fernandez-Castaneda, A. et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell 185, 2452\u201368 e16 (2022).","journal-title":"Cell"},{"key":"1205_CR68","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12933-022-01579-5","volume":"21","author":"E Pretorius","year":"2022","unstructured":"Pretorius, E. et al. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with long COVID\/post-acute sequelae of COVID-19 (PASC). Cardiovasc. Diabetol. 21, 148 (2022).","journal-title":"Cardiovasc. Diabetol."},{"key":"1205_CR69","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1161\/HYPERTENSIONAHA.119.13023","volume":"75","author":"SP Rensma","year":"2020","unstructured":"Rensma, S. P. et al. Microvascular dysfunction is associated with worse cognitive performance: the Maastricht Study. Hypertension 75, 237\u2013245 (2020).","journal-title":"Hypertension"},{"key":"1205_CR70","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41586-022-04569-5","volume":"604","author":"G Douaud","year":"2022","unstructured":"Douaud, G. et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 604, 697\u2013707 (2022).","journal-title":"Nature"},{"key":"1205_CR71","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mus.27940","volume":"68","author":"RMC Abrams","year":"2023","unstructured":"Abrams, R. M. C., Zhou, L. & Shin, S. C. Persistent post-COVID-19 neuromuscular symptoms. Muscle Nerve 68, 350\u2013355 (2023).","journal-title":"Muscle Nerve"},{"key":"1205_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120162","volume":"434","author":"L Premraj","year":"2022","unstructured":"Premraj, L. et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J. Neurol. Sci. 434, 120162 (2022).","journal-title":"J. Neurol. Sci."},{"key":"1205_CR73","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/jns.12482","volume":"27","author":"A Taga","year":"2022","unstructured":"Taga, A. & Lauria, G. COVID-19 and the peripheral nervous system. A 2-year review from the pandemic to the vaccine era. J. Peripher. Nerv. Syst. 27, 4\u201330 (2022).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"1205_CR74","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001146","volume":"9","author":"AL Oaklander","year":"2022","unstructured":"Oaklander, A. L. et al. Peripheral neuropathy evaluations of patients with prolonged long COVID. Neurol. Neuroimmunol. Neuroinflamm. 9, e1146 (2022).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"1205_CR75","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1097\/j.pain.0000000000003259","volume":"165","author":"P Falco","year":"2024","unstructured":"Falco, P. et al. Small fibre neuropathy frequently underlies the painful long-COVID syndrome. Pain 165, 2002\u20132010 (2024).","journal-title":"Pain"},{"key":"1205_CR76","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000546015","volume":"88","author":"N Drobinska","year":"2025","unstructured":"Drobinska, N. et al. Small fiber neuropathy in long COVID: a cohort study with multimodal assessment and follow-up. Eur. Neurol. 88, 52\u201363 (2025).","journal-title":"Eur. Neurol."},{"key":"1205_CR77","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.genhosppsych.2024.02.009","volume":"88","author":"C van der Feltz-Cornelis","year":"2024","unstructured":"van der Feltz-Cornelis, C. et al. Prevalence of mental health conditions and brain fog in people with long COVID: a systematic review and meta-analysis. Gen. Hosp. Psychiatry 88, 10\u201322 (2024).","journal-title":"Gen. Hosp. Psychiatry"},{"key":"1205_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1138389","volume":"14","author":"M Marchi","year":"2023","unstructured":"Marchi, M. et al. Psychiatric symptoms in long-COVID patients: a systematic review. Front. Psychiatry 14, 1138389 (2023).","journal-title":"Front. Psychiatry"},{"key":"1205_CR79","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1038\/s41380-022-01638-z","volume":"27","author":"K Yuan","year":"2022","unstructured":"Yuan, K. et al. A systematic review and meta-analysis on prevalence of and risk factors associated with depression, anxiety and insomnia in infectious diseases, including COVID-19: a call to action. Mol. Psychiatry 27, 3214\u20133222 (2022).","journal-title":"Mol. Psychiatry"},{"key":"1205_CR80","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S2215-0366(22)00260-7","volume":"9","author":"M Taquet","year":"2022","unstructured":"Taquet, M. et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1,284,437 patients. Lancet Psychiatry 9, 815\u2013827 (2022).","journal-title":"Lancet Psychiatry"},{"key":"1205_CR81","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/S2215-0366(24)00214-1","volume":"11","author":"M Taquet","year":"2024","unstructured":"Taquet, M. et al. Cognitive and psychiatric symptom trajectories 2\u20133 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK. Lancet Psychiatry 11, 696\u2013708 (2024).","journal-title":"Lancet Psychiatry"},{"key":"1205_CR82","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41590-023-01724-6","volume":"25","author":"K Yin","year":"2024","unstructured":"Yin, K. et al. Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. Nat. Immunol. 25, 218\u2013225 (2024).","journal-title":"Nat. Immunol."},{"key":"1205_CR83","doi-asserted-by":"publisher","first-page":"e0284075","DOI":"10.1371\/journal.pone.0284075","volume":"18","author":"H Zakia","year":"2023","unstructured":"Zakia, H., Pradana, K. & Iskandar, S. Risk factors for psychiatric symptoms in patients with long COVID: a systematic review. PLoS ONE 18, e0284075 (2023).","journal-title":"PLoS ONE"},{"key":"1205_CR84","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/pcn.13508","volume":"77","author":"T Kubota","year":"2023","unstructured":"Kubota, T., Kuroda, N. & Sone, D. Neuropsychiatric aspects of long COVID: a comprehensive review. Psychiatry Clin. Neurosci. 77, 84\u201393 (2023).","journal-title":"Psychiatry Clin. Neurosci."},{"key":"1205_CR85","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41380-022-01614-7","volume":"28","author":"N Zeng","year":"2023","unstructured":"Zeng, N. et al. A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action. Mol. Psychiatry 28, 423\u2013433 (2023).","journal-title":"Mol. Psychiatry"},{"key":"1205_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-025-07655-w","volume":"26","author":"J Wen","year":"2025","unstructured":"Wen, J. et al. Trajectories of symptoms in the acute phase of COVID-19 infection and their association with anxiety and depression 2\u2009years after infection. BMC Psychiatry 26, 29 (2025).","journal-title":"BMC Psychiatry"},{"key":"1205_CR87","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1007\/s11469-021-00659-z","volume":"21","author":"J Huarcaya-Victoria","year":"2023","unstructured":"Huarcaya-Victoria, J. et al. Mental health in COVID-2019 survivors from a general hospital in Peru: sociodemographic, clinical, and inflammatory variable associations. Int. J. Ment. Health Addict. 21, 1264\u20131285 (2023).","journal-title":"Int. J. Ment. Health Addict."},{"key":"1205_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2021.114243","volume":"305","author":"GK Ahmed","year":"2021","unstructured":"Ahmed, G. K. et al. Long term impact of COVID-19 infection on sleep and mental health: a cross-sectional study. Psychiatry Res. 305, 114243 (2021).","journal-title":"Psychiatry Res."},{"key":"1205_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2021.105295","volume":"131","author":"N Kappelmann","year":"2021","unstructured":"Kappelmann, N., Dantzer, R. & Khandaker, G. M. Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19. Psychoneuroendocrinology 131, 105295 (2021).","journal-title":"Psychoneuroendocrinology"},{"key":"1205_CR90","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.bbi.2024.12.006","volume":"124","author":"F Couto Amendola","year":"2025","unstructured":"Couto Amendola, F. et al. A two-year cohort study examining the impact of cytokines and chemokines on cognitive and psychiatric outcomes in long-COVID-19 patients. Brain Behav. Immun. 124, 218\u2013225 (2025).","journal-title":"Brain Behav. Immun."},{"key":"1205_CR91","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1111\/ene.15721","volume":"30","author":"T Teodoro","year":"2023","unstructured":"Teodoro, T., Chen, J., Gelauff, J. & Edwards, M. J. Functional neurological disorder in people with long COVID: a systematic review. Eur. J. Neurol. 30, 1505\u20131514 (2023).","journal-title":"Eur. J. Neurol."},{"key":"1205_CR92","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3390\/jpm14080799","volume":"14","author":"TE Davenport","year":"2024","unstructured":"Davenport, T. E. et al. Long COVID is not a functional neurologic disorder. J. Pers. Med. 14, 799 (2024).","journal-title":"J. Pers. Med."},{"key":"1205_CR93","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3390\/v15030783","volume":"15","author":"CM Van der Feltz-Cornelis","year":"2023","unstructured":"Van der Feltz-Cornelis, C. M., Moriarty, A. S. & Strain, W. D. Neurological dysfunction in long COVID should not be labelled as functional neurological disorder. Viruses 15, 783 (2023).","journal-title":"Viruses"},{"key":"1205_CR94","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis, H. E., McCorkell, L., Vogel, J. M. & Topol, E. J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 21, 133\u2013146 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"1205_CR95","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s41586-022-05542-y","volume":"612","author":"SR Stein","year":"2022","unstructured":"Stein, S. R. et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature 612, 758\u2013763 (2022).","journal-title":"Nature"},{"key":"1205_CR96","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S1473-3099(24)00171-3","volume":"24","author":"W Zuo","year":"2024","unstructured":"Zuo, W. et al. The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China. Lancet Infect. Dis. 24, 845\u2013855 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"1205_CR97","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg2248","volume":"9","author":"R Mart\u00ednez-M\u00e1rmol","year":"2023","unstructured":"Mart\u00ednez-M\u00e1rmol, R. et al. SARS-CoV-2 infection and viral fusogens cause neuronal and glial fusion that compromises neuronal activity. Sci. Adv. 9, eadg2248 (2023).","journal-title":"Sci. Adv."},{"key":"1205_CR98","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1016\/j.neuron.2022.11.007","volume":"110","author":"M Khan","year":"2022","unstructured":"Khan, M. et al. Anatomical barriers against SARS-CoV-2 neuroinvasion at vulnerable interfaces visualized in deceased COVID-19 patients. Neuron 110, 3919\u201335.e6 (2022).","journal-title":"Neuron"},{"key":"1205_CR99","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41593-020-00758-5","volume":"24","author":"J Meinhardt","year":"2021","unstructured":"Meinhardt, J. et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat. Neurosci. 24, 168\u2013175 (2021).","journal-title":"Nat. Neurosci."},{"key":"1205_CR100","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1016\/j.cell.2023.09.013","volume":"186","author":"AC Wong","year":"2023","unstructured":"Wong, A. C. et al. Serotonin reduction in post-acute sequelae of viral infection. Cell 186, 4851\u201367.e20 (2023).","journal-title":"Cell"},{"key":"1205_CR101","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S0140-6736(24)01136-X","volume":"404","author":"T Greenhalgh","year":"2024","unstructured":"Greenhalgh, T., Sivan, M., Perlowski, A. & Nikolich, J. \u017d Long COVID: a clinical update. Lancet 404, 707\u2013724 (2024).","journal-title":"Lancet"},{"key":"1205_CR102","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41586-023-06651-y","volume":"623","author":"J Klein","year":"2023","unstructured":"Klein, J. et al. Distinguishing features of long COVID identified through immune profiling. Nature 623, 139\u2013148 (2023).","journal-title":"Nature"},{"key":"1205_CR103","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1440324","volume":"15","author":"C Dunai","year":"2024","unstructured":"Dunai, C. et al. Pulmonary SARS-CoV-2 infection leads to para-infectious immune activation in the brain. Front. Immunol. 15, 1440324 (2024).","journal-title":"Front. Immunol."},{"key":"1205_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42320-4","volume":"14","author":"BD Michael","year":"2023","unstructured":"Michael, B. D. et al. Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses. Nat. Commun. 14, 8487 (2023).","journal-title":"Nat. Commun."},{"key":"1205_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34068-0","volume":"13","author":"MM Etter","year":"2022","unstructured":"Etter, M. M. et al. Severe neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study. Nat. Commun. 13, 6777 (2022).","journal-title":"Nat. Commun."},{"key":"1205_CR106","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1093\/brain\/awac321","volume":"145","author":"EJ Needham","year":"2022","unstructured":"Needham, E. J. et al. Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses. Brain 145, 4097\u20134107 (2022).","journal-title":"Brain"},{"key":"1205_CR107","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3390\/pathogens10060763","volume":"10","author":"JE Gold","year":"2021","unstructured":"Gold, J. E., Okyay, R. A., Licht, W. E. & Hurley, D. J. Investigation of long COVID prevalence and its relationship to Epstein\u2013Barr virus reactivation. Pathogens 10, 763 (2021).","journal-title":"Pathogens"},{"key":"1205_CR108","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","volume":"185","author":"Y Su","year":"2022","unstructured":"Su, Y. et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 185, 881\u201395.e20 (2022).","journal-title":"Cell"},{"key":"1205_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.656797","volume":"12","author":"M Ruiz-Pablos","year":"2021","unstructured":"Ruiz-Pablos, M., Paiva, B., Montero-Mateo, R., Garcia, N. & Zabaleta, A. Epstein\u2013Barr virus and the origin of myalgic encephalomyelitis or chronic fatigue syndrome. Front. Immunol. 12, 656797 (2021).","journal-title":"Front. Immunol."},{"key":"1205_CR110","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1016\/j.neuron.2022.10.006","volume":"110","author":"M Monje","year":"2022","unstructured":"Monje, M. & Iwasaki, A. The neurobiology of long COVID. Neuron 110, 3484\u20133496 (2022).","journal-title":"Neuron"},{"key":"1205_CR111","first-page":"160","volume":"19","author":"K Bjornevik","year":"2023","unstructured":"Bjornevik, K., M\u00fcnz, C., Cohen, J. I. & Ascherio, A. Epstein\u2013Barr virus as a leading cause of multiple sclerosis: mechanisms and implications. Nat. Rev. Neurol. 19, 160\u2013171 (2023).","journal-title":"Nat. Rev. Neurol."},{"key":"1205_CR112","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1093\/brain\/awab148","volume":"144","author":"KT Thakur","year":"2021","unstructured":"Thakur, K. T. et al. COVID-19 neuropathology at Columbia University Irving Medical Center\/New York Presbyterian Hospital. Brain 144, 2696\u20132708 (2021).","journal-title":"Brain"},{"key":"1205_CR113","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga, Z. et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 395, 1417\u20131418 (2020).","journal-title":"Lancet"},{"key":"1205_CR114","doi-asserted-by":"publisher","first-page":"816","DOI":"10.3390\/cells12050816","volume":"12","author":"A Leng","year":"2023","unstructured":"Leng, A. et al. Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics. Cells 12, 816 (2023).","journal-title":"Cells"},{"key":"1205_CR115","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1111\/jth.15490","volume":"19","author":"H Fogarty","year":"2021","unstructured":"Fogarty, H. et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J. Thromb. Haemost. 19, 2546\u20132553 (2021).","journal-title":"J. Thromb. Haemost."},{"key":"1205_CR116","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12933-021-01359-7","volume":"20","author":"E Pretorius","year":"2021","unstructured":"Pretorius, E. et al. Persistent clotting protein pathology in long COVID\/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 20, 172 (2021).","journal-title":"Cardiovasc. Diabetol."},{"key":"1205_CR117","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41593-024-01576-9","volume":"27","author":"C Greene","year":"2024","unstructured":"Greene, C. et al. Blood\u2013brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat. Neurosci. 27, 421\u2013432 (2024).","journal-title":"Nat. Neurosci."},{"key":"1205_CR118","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd3876","volume":"12","author":"Y Zuo","year":"2020","unstructured":"Zuo, Y. et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci. Transl. Med. 12, eabd3876 (2020).","journal-title":"Sci. Transl. Med."},{"key":"1205_CR119","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkaa081","volume":"5","author":"ML Tung","year":"2021","unstructured":"Tung, M. L., Tan, B., Cherian, R. & Chandra, B. Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots. Rheumatol. Adv. Pract. 5, rkaa081 (2021).","journal-title":"Rheumatol. Adv. Pract."},{"key":"1205_CR120","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s41577-023-00904-7","volume":"23","author":"DM Altmann","year":"2023","unstructured":"Altmann, D. M., Whettlock, E. M., Liu, S., Arachchillage, D. J. & Boyton, R. J. The immunology of long COVID. Nat. Rev. Immunol. 23, 618\u2013634 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"1205_CR121","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1136\/gutjnl-2021-325989","volume":"71","author":"Q Liu","year":"2022","unstructured":"Liu, Q. et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut 71, 544\u2013552 (2022).","journal-title":"Gut"},{"key":"1205_CR122","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1473-3099(23)00685-0","volume":"24","author":"RI Lau","year":"2024","unstructured":"Lau, R. I. et al. A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial. Lancet Infect. Dis. 24, 256\u2013265 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"1205_CR123","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1080043","volume":"14","author":"G Ancona","year":"2023","unstructured":"Ancona, G. et al. Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID. Front. Immunol. 14, 1080043 (2023).","journal-title":"Front. Immunol."},{"key":"1205_CR124","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1007\/s00415-022-11047-5","volume":"269","author":"G Cecchetti","year":"2022","unstructured":"Cecchetti, G. et al. Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study. J. Neurol. 269, 3400\u20133412 (2022).","journal-title":"J. Neurol."},{"key":"1205_CR125","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2217232120","volume":"120","author":"M Petersen","year":"2023","unstructured":"Petersen, M. et al. Brain imaging and neuropsychological assessment of individuals recovered from a mild to moderate SARS-CoV-2 infection. Proc. Natl Acad. Sci. USA 120, e2217232120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1205_CR126","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.cortex.2025.04.004","volume":"187","author":"B Samanci","year":"2025","unstructured":"Samanci, B. et al. Persistent neurocognitive deficits in long COVID: evidence of structural changes and network abnormalities following mild infection. Cortex 187, 98\u2013110 (2025).","journal-title":"Cortex"},{"key":"1205_CR127","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291725000054","volume":"55","author":"M Troll","year":"2025","unstructured":"Troll, M. et al. Altered corticostriatal connectivity in long-COVID patients is associated with cognitive impairment. Psychol. Med. 55, e49 (2025).","journal-title":"Psychol. Med."},{"key":"1205_CR128","doi-asserted-by":"publisher","first-page":"e2356098","DOI":"10.1001\/jamanetworkopen.2023.56098","volume":"7","author":"A Jaywant","year":"2024","unstructured":"Jaywant, A. et al. Cognitive symptoms of post-COVID-19 condition and daily functioning. JAMA Netw. Open 7, e2356098\u2013e2356098 (2024).","journal-title":"JAMA Netw. Open"},{"key":"1205_CR129","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/s41591-024-02987-8","volume":"30","author":"M Cai","year":"2024","unstructured":"Cai, M., Xie, Y., Topol, E. J. & Al-Aly, Z. Three-year outcomes of post-acute sequelae of COVID-19. Nat. Med. 30, 1564\u20131573 (2024).","journal-title":"Nat. Med."},{"key":"1205_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-80833-0","volume":"15","author":"RSK Shil","year":"2025","unstructured":"Shil, R. S. K. et al. Patients with neurological or psychiatric complications of COVID-19 have worse long-term functional outcomes: COVID-CNS \u2014 a multicentre case\u2013control study. Sci. Rep. 15, 3443 (2025).","journal-title":"Sci. Rep."},{"key":"1205_CR131","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-36995-4","volume":"13","author":"Y Kim","year":"2023","unstructured":"Kim, Y., Bae, S., Chang, H. H. & Kim, S. W. Long COVID prevalence and impact on quality of life 2 years after acute COVID-19. Sci. Rep. 13, 11207 (2023).","journal-title":"Sci. Rep."},{"key":"1205_CR132","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2024.1394068","volume":"15","author":"AN Rodrigues","year":"2024","unstructured":"Rodrigues, A. N. et al. Effect of long COVID-19 syndrome on health-related quality of life: a cross-sectional study. Front. Psychol. 15, 1394068 (2024).","journal-title":"Front. Psychol."},{"key":"1205_CR133","unstructured":"World Health Organization. WHO Guidelines Approved by the Guidelines Review Committee. Clinical Management of COVID-19: Living Guideline (WHO, 2022)."},{"key":"1205_CR134","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/cid\/ciad257","volume":"77","author":"TA Kuut","year":"2023","unstructured":"Kuut, T. A. et al. Efficacy of cognitive-behavioral therapy targeting severe fatigue following coronavirus disease 2019: results of a randomized controlled trial. Clin. Infect. Dis. 77, 687\u2013695 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"1205_CR135","doi-asserted-by":"publisher","first-page":"e2534304","DOI":"10.1001\/jamanetworkopen.2025.34304","volume":"8","author":"C Berry","year":"2025","unstructured":"Berry, C. et al. Resistance exercise therapy after COVID-19 infection: a randomized clinical trial. JAMA Netw. Open 8, e2534304 (2025).","journal-title":"JAMA Netw. Open"},{"key":"1205_CR136","doi-asserted-by":"publisher","first-page":"6739","DOI":"10.3390\/jcm12216739","volume":"12","author":"JM Mooren","year":"2023","unstructured":"Mooren, J. M. et al. Medical rehabilitation of patients with post-COVID-19 syndrome \u2014 a comparison of aerobic interval and continuous training. J. Clin. Med. 12, 6739 (2023).","journal-title":"J. Clin. Med."},{"key":"1205_CR137","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/pmrj.12894","volume":"14","author":"S Blitshteyn","year":"2022","unstructured":"Blitshteyn, S. et al. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of autonomic dysfunction in patients with post-acute sequelae of SARS-CoV-2 infection (PASC). PM R 14, 1270\u20131291 (2022).","journal-title":"PM R"},{"key":"1205_CR138","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-61455-y","volume":"14","author":"L Rinaldi","year":"2024","unstructured":"Rinaldi, L. et al. Long-COVID autonomic syndrome in working age and work ability impairment. Sci. Rep. 14, 11835 (2024).","journal-title":"Sci. Rep."},{"key":"1205_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.123081","volume":"357","author":"TE Herring","year":"2024","unstructured":"Herring, T. E. et al. Post traumatic stress and sleep disorders in long COVID: patient management and treatment. Life Sci. 357, 123081 (2024).","journal-title":"Life Sci."},{"key":"1205_CR140","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s00406-023-01721-8","volume":"274","author":"RSK Shil","year":"2024","unstructured":"Shil, R. S. K. et al. A clinical approach to the investigation and management of long COVID associated neuropathic pain. Eur. Arch. Psychiatry Clin. Neurosci. 274, 1787\u20131795 (2024).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"1205_CR141","unstructured":"National Institute for Health and Care Excellence. Neuropathic pain in adults: pharmacological management in non-specialist settings. nice.org.uk https:\/\/www.nice.org.uk\/guidance\/cg173\/chapter\/Recommendations (2020)."},{"key":"1205_CR142","doi-asserted-by":"publisher","first-page":"e2436874","DOI":"10.1001\/jamanetworkopen.2024.36874","volume":"7","author":"T Guttuso Jr.","year":"2024","unstructured":"Guttuso, T. Jr., Zhu, J. & Wilding, G. E. Lithium aspartate for long COVID fatigue and cognitive dysfunction: a randomized clinical trial. JAMA Netw. Open 7, e2436874 (2024).","journal-title":"JAMA Netw. Open"},{"key":"1205_CR143","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/brain\/awad377","volume":"147","author":"RS McIntyre","year":"2024","unstructured":"McIntyre, R. S. et al. Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial. Brain 147, 849\u2013857 (2024).","journal-title":"Brain"},{"key":"1205_CR144","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1001\/jamainternmed.2024.2007","volume":"184","author":"LN Geng","year":"2024","unstructured":"Geng, L. N. et al. Nirmatrelvir\u2013ritonavir and symptoms in adults with postacute sequelae of SARS-CoV-2 infection: the STOP-PASC randomized clinical trial. JAMA Intern. Med. 184, 1024\u20131034 (2024).","journal-title":"JAMA Intern. Med."},{"key":"1205_CR145","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1093\/cid\/ciac226","volume":"75","author":"NB Gaylis","year":"2022","unstructured":"Gaylis, N. B. et al. Reduced cell surface levels of C-C chemokine receptor 5 and immunosuppression in long coronavirus disease 2019 syndrome. Clin. Infect. Dis. 75, 1232\u20131234 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"1205_CR146","first-page":"1285","volume":"94","author":"MM Tanashyan","year":"2022","unstructured":"Tanashyan, M. M., Raskurazhev, A. A., Kuznetsova, P. I., Bely, P. A. & Zaslavskaya, K. I. Prospects and possibilities for the treatment of patients with long COVID-19 syndrome. Ter. Arkh. 94, 1285\u20131293 (2022).","journal-title":"Ter. Arkh."},{"key":"1205_CR147","doi-asserted-by":"publisher","first-page":"45","DOI":"10.17116\/jnevro202112110145","volume":"121","author":"MV Putilina","year":"2021","unstructured":"Putilina, M. V., Teplova, N. V., Bairova, K. I., Petrikeeva, A. E. & Shabalina, N. I. The result of prospective randomized study CITADEL \u2014 the efficacy and safety of drug cytoflavin in postcovid rehabilitation. Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova 121, 45\u201351 (2021).","journal-title":"Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova"},{"key":"1205_CR148","doi-asserted-by":"publisher","first-page":"4984","DOI":"10.3390\/nu14234984","volume":"14","author":"M Tosato","year":"2022","unstructured":"Tosato, M. et al. Effects of l-arginine plus vitamin c supplementation on physical performance, endothelial function, and persistent fatigue in adults with long COVID: a single-blind randomized controlled trial. Nutrients 14, 4984 (2022).","journal-title":"Nutrients"},{"key":"1205_CR149","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1038\/s41380-023-02084-1","volume":"28","author":"M Achleitner","year":"2023","unstructured":"Achleitner, M. et al. Clinical improvement of long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis. Mol. Psychiatry 28, 2872\u20132877 (2023).","journal-title":"Mol. Psychiatry"},{"key":"1205_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.ensci.2020.100276","volume":"21","author":"P Novak","year":"2020","unstructured":"Novak, P. Post COVID-19 syndrome associated with orthostatic cerebral hypoperfusion syndrome, small fiber neuropathy and benefit of immunotherapy: a case report. eNeurologicalSci 21, 100276 (2020).","journal-title":"eNeurologicalSci"},{"key":"1205_CR151","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1129459","volume":"14","author":"H Bonilla","year":"2023","unstructured":"Bonilla, H. et al. Therapeutic trials for long COVID-19: a call to action from the interventions taskforce of the RECOVER initiative. Front. Immunol. 14, 1129459 (2023).","journal-title":"Front. Immunol."},{"key":"1205_CR152","doi-asserted-by":"crossref","unstructured":"Preview : Journal Type Where are the long COVID trials? Lancet Infect. Dis. 23, 879 (2023).","DOI":"10.1016\/S1473-3099(23)00440-1"},{"key":"1205_CR153","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/d41586-022-02140-w","volume":"608","author":"H Ledford","year":"2022","unstructured":"Ledford, H. Long-COVID treatments: why the world is still waiting. Nature 608, 258\u2013260 (2022).","journal-title":"Nature"},{"key":"1205_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101624","volume":"53","author":"KI Notarte","year":"2022","unstructured":"Notarte, K. I. et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review. EClinicalMedicine 53, 101624 (2022).","journal-title":"EClinicalMedicine"},{"key":"1205_CR155","doi-asserted-by":"publisher","first-page":"e069676","DOI":"10.1136\/bmj-2021-069676","volume":"377","author":"D Ayoubkhani","year":"2022","unstructured":"Ayoubkhani, D. et al. Trajectory of long covid symptoms after COVID-19 vaccination: community based cohort study. Br. Med. J. 377, e069676 (2022).","journal-title":"Br. Med. J."},{"key":"1205_CR156","doi-asserted-by":"publisher","first-page":"e072529","DOI":"10.1136\/bmj-2022-072529","volume":"380","author":"B Mizrahi","year":"2023","unstructured":"Mizrahi, B. et al. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. Br. Med. J. 380, e072529 (2023).","journal-title":"Br. Med. J."},{"key":"1205_CR157","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S1474-4422(20)30221-0","volume":"19","author":"MA Ellul","year":"2020","unstructured":"Ellul, M. A. et al. Neurological associations of COVID-19. Lancet Neurol. 19, 767\u2013783 (2020).","journal-title":"Lancet Neurol."},{"key":"1205_CR158","doi-asserted-by":"publisher","first-page":"e1003773","DOI":"10.1371\/journal.pmed.1003773","volume":"18","author":"M Taquet","year":"2021","unstructured":"Taquet, M. et al. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 18, e1003773 (2021).","journal-title":"PLoS Med."},{"key":"1205_CR159","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02003-7","volume":"19","author":"\u00c1 Romero-Duarte","year":"2021","unstructured":"Romero-Duarte, \u00c1 et al. Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study. BMC Med. 19, 129 (2021).","journal-title":"BMC Med."},{"key":"1205_CR160","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S2213-2600(22)00126-6","volume":"10","author":"L Huang","year":"2022","unstructured":"Huang, L. et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir. Med. 10, 863\u2013876 (2022).","journal-title":"Lancet Respir. Med."},{"key":"1205_CR161","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02448-4","volume":"20","author":"E Pazukhina","year":"2022","unstructured":"Pazukhina, E. et al. Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12\u2009months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID). BMC Med. 20, 244 (2022).","journal-title":"BMC Med."},{"key":"1205_CR162","doi-asserted-by":"publisher","first-page":"e2238804","DOI":"10.1001\/jamanetworkopen.2022.38804","volume":"5","author":"RH Perlis","year":"2022","unstructured":"Perlis, R. H. et al. Prevalence and Correlates of Long COVID Symptoms Among US Adults. JAMA Netw. Open 5, e2238804 (2022).","journal-title":"JAMA Netw. Open"},{"key":"1205_CR163","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29521-z","volume":"13","author":"M Whitaker","year":"2022","unstructured":"Whitaker, M. et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat. Commun. 13, 1957 (2022).","journal-title":"Nat. Commun."},{"key":"1205_CR164","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1038\/s41380-023-01951-1","volume":"28","author":"Y Zhao","year":"2023","unstructured":"Zhao, Y. et al. The phenotype and prediction of long-term physical, mental and cognitive COVID-19 sequelae 20 months after recovery, a community-based cohort study in China. Mol. Psychiatry 28, 1793\u20131801 (2023).","journal-title":"Mol. Psychiatry"},{"key":"1205_CR165","doi-asserted-by":"publisher","first-page":"e0296488","DOI":"10.1371\/journal.pone.0296488","volume":"19","author":"PSK Tok","year":"2024","unstructured":"Tok, P. S. K. et al. Post COVID-19 condition among adults in Malaysia following the Omicron wave: a prospective cohort study. PLoS ONE 19, e0296488 (2024).","journal-title":"PLoS ONE"},{"key":"1205_CR166","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2220578","volume":"12","author":"J Cai","year":"2023","unstructured":"Cai, J. et al. A one-year follow-up study of systematic impact of long COVID symptoms among patients post SARS-CoV-2 omicron variants infection in Shanghai, China. Emerg. Microbes Infect. 12, 2220578 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"1205_CR167","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/S2213-2600(20)30404-5","volume":"8","author":"DE Leisman","year":"2020","unstructured":"Leisman, D. E. et al. Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes. Lancet Respir. Med. 8, 1233\u20131244 (2020).","journal-title":"Lancet Respir. Med."},{"key":"1205_CR168","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.1007\/s00415-022-11233-5","volume":"269","author":"F Verde","year":"2022","unstructured":"Verde, F. et al. Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations. J. Neurol. 269, 5691\u20135701 (2022).","journal-title":"J. Neurol."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01205-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01205-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01205-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:03:22Z","timestamp":1780574602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01205-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":168,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1205"],"URL":"https:\/\/doi.org\/10.1038\/s41582-026-01205-y","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"31 March 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}